Repertoire Immune Medicines, a biotechnology startup formed by Flagship Pioneering, announced Monday a deal with Bristol Myers Squibb to create vaccines that can rebalance the immune systems of people with autoimmune diseases.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,